Immunodiagnostic System HDQ operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immunodiagnostic System HDQ with three other
pharmaceutical manufacturers in Europe:
Vistin Pharma ASA
sales of 394.03 million Norwegian Kroner [US$47.30 million]
Opimus Group Nyrt
(15.31 billion Hungarian Forints [US$55.75 million]
Sanochemia Pharmazeutika AG
based in Austria
(39.30 million Euro [US$44.11 million]
of which 64%
was Human Pharmaceuticals).
During the year ended March of 2016, sales at
Immunodiagnostic System HDQ were £38.31 million (US$49.68 million).
decrease of 15.6%
versus 2015, when the company's sales were £45.36 million.